Literature DB >> 20393403

The role of perfluorocarbon in organ preservation.

Sarah A Hosgood, Michael L Nicholson.   

Abstract

Perfluorocarbons (PFCs) are inert solutions that have a high capacity for dissolving oxygen. There has been a continuing level of research into the delivery of oxygen during solid organ preservation with the use of PFCs. The one- and two-layer methods have been used as static storage techniques, proving particularly successful for pancreas preservation. They can also be formulated as an emulsion for continual perfusion or as a simple flush solution. The success of PFCs in organ preservation seems to be somewhat organ and species dependant, and further experimental evidence is needed to establish their application.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393403     DOI: 10.1097/TP.0b013e3181da6064

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.

Authors:  Junjie Chen; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

2.  Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes.

Authors:  Kyoko Honda-Kohmo; Robert Hutcheson; Kim E Innes; Baqiyyah N Conway
Journal:  J Diabetes Complications       Date:  2019-02-20       Impact factor: 2.852

Review 3.  Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.

Authors:  Joice Maria Joseph; Maria Rosa Gigliobianco; Bita Mahdavi Firouzabadi; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

4.  Perfluoroalkyl substances and beta cell deficient diabetes.

Authors:  Baqiyyah Conway; Karen E Innes; Dustin Long
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

Review 5.  The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.

Authors:  M Mendes-Braz; M Elias-Miró; M B Jiménez-Castro; A Casillas-Ramírez; F S Ramalho; C Peralta
Journal:  J Biomed Biotechnol       Date:  2012-05-09

6.  Endobronchial perfluorocarbon reduces inflammatory activity before and after lung transplantation in an animal experimental model.

Authors:  Luiz Alberto Forgiarini Junior; Arthur Rodrigo Ronconi Holand; Luiz Felipe Forgiarini; Darlan Pase da Rosa; Norma Anair Possa Marroni; Paulo Francisco Guerreiro Cardoso; Cristiano Feijó Andrade
Journal:  Mediators Inflamm       Date:  2013-12-26       Impact factor: 4.711

7.  Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes.

Authors:  Baqiyyah N Conway; Ashley N Badders; Tina Costacou; John M Arthur; Kim E Innes
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-15       Impact factor: 3.168

Review 8.  Pancreas Transplantation from Donors after Circulatory Death: an Irrational Reluctance?

Authors:  M Leemkuil; H G D Leuvenink; R A Pol
Journal:  Curr Diab Rep       Date:  2019-11-18       Impact factor: 4.810

9.  The efficacy of HBOC-201 in ex situ gradual rewarming kidney perfusion in a rat model.

Authors:  Paria Mahboub; Mohamed Aburawi; Negin Karimian; Florence Lin; Murat Karabacak; Fermin Fontan; Shannon N Tessier; James Markmann; Heidi Yeh; Korkut Uygun
Journal:  Artif Organs       Date:  2019-08-01       Impact factor: 3.094

10.  Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.

Authors:  Eloy Erro; James Bundy; Isobel Massie; Sherri-Ann Chalmers; Aude Gautier; Spyridon Gerontas; Mike Hoare; Peter Sharratt; Sarah Choudhury; Marcin Lubowiecki; Ian Llewellyn; Cécile Legallais; Barry Fuller; Humphrey Hodgson; Clare Selden
Journal:  Biores Open Access       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.